Pharma v. Solux Corp.

Federal Circuit

Pharma v. Solux Corp.

562 F. App'x 981

CourtCourt of Appeals for the Federal Circuit

DecidedApril 24, 2014

DocketNos. 2013-1672, 2014-1287

StatusPublished

This text of 562 F. App'x 981 (Pharma v. Solux Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Pharma v. Solux Corp., 562 F. App'x 981 (Fed. Cir. 2014).

Pincite

Opinion

ON MOTION

ORDER

Solux Corporation moves to voluntarily dismiss Appeal No. 2013-1672. Synbias Pharma responds. Synbias moves without opposition for an extension of time to file its opening brief in Appeal No. 14-1287 by June 4, 2014.

Solux requests that its appeal be dismissed “neither with nor without prejudice.” The court generally does not indicate whether an appeal is dismissed with or without prejudice. Instead, it is the court’s practice to simply “dismiss” when an appellant seeks to voluntarily dismiss its appeal.

Accordingly,

It Is Ordered That:

(1) The motion to dismiss is granted. Appeal No. 2013-1672 is dismissed.

(2) Each party shall bear its own costs in Appeal No. 2013-1672.

(3) The revised official caption for Appeal No. 2014-1287 is reflected above.

(4) The motion for extension of time is granted. Synbias’s opening brief in Appeal No. 2014-1287 shall be due by June 4, 2014.

Free access — add to your briefcase to read the full text and ask questions with AI